OFI Invest Asset Management acquired a new stake in shares of AMETEK, Inc. (NYSE:AME – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 248 shares of the technology company’s stock, valued at approximately $43,000.
Other large investors have also bought and sold shares of the company. Itau Unibanco Holding S.A. boosted its position in AMETEK by 62.6% during the 3rd quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company’s stock valued at $34,000 after acquiring an additional 77 shares in the last quarter. Versant Capital Management Inc boosted its position in AMETEK by 3,116.7% during the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company’s stock valued at $35,000 after acquiring an additional 187 shares in the last quarter. AdvisorNet Financial Inc boosted its position in AMETEK by 1,176.5% during the 4th quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company’s stock valued at $39,000 after acquiring an additional 200 shares in the last quarter. Geneos Wealth Management Inc. boosted its position in AMETEK by 42.9% during the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after acquiring an additional 70 shares in the last quarter. Finally, Anchor Investment Management LLC lifted its holdings in shares of AMETEK by 366.1% during the third quarter. Anchor Investment Management LLC now owns 261 shares of the technology company’s stock valued at $45,000 after purchasing an additional 205 shares during the last quarter. 87.43% of the stock is owned by institutional investors.
AMETEK Stock Performance
AME stock opened at $179.38 on Tuesday. The stock has a market capitalization of $41.37 billion, a PE ratio of 30.25, a price-to-earnings-growth ratio of 2.73 and a beta of 1.14. AMETEK, Inc. has a 12-month low of $149.03 and a 12-month high of $198.33. The company has a current ratio of 1.24, a quick ratio of 0.75 and a debt-to-equity ratio of 0.15. The stock’s 50 day simple moving average is $183.35 and its 200 day simple moving average is $180.13.
AMETEK Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, March 14th will be issued a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 0.69%. This is a boost from AMETEK’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 14th. AMETEK’s dividend payout ratio is presently 20.91%.
AMETEK announced that its board has approved a stock repurchase program on Friday, February 7th that authorizes the company to repurchase $1.25 billion in shares. This repurchase authorization authorizes the technology company to repurchase up to 2.9% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board of directors believes its stock is undervalued.
Wall Street Analyst Weigh In
AME has been the subject of several recent research reports. StockNews.com upgraded shares of AMETEK from a “hold” rating to a “buy” rating in a report on Sunday. BNP Paribas upgraded shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 target price for the company in a report on Thursday, January 16th. Truist Financial lifted their target price on shares of AMETEK from $221.00 to $222.00 and gave the company a “buy” rating in a report on Thursday, January 16th. Bank of America upgraded shares of AMETEK from a “neutral” rating to a “buy” rating and lifted their target price for the company from $195.00 to $225.00 in a report on Monday, December 16th. Finally, KeyCorp lifted their target price on shares of AMETEK from $205.00 to $215.00 and gave the company an “overweight” rating in a report on Friday, November 22nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $204.67.
Check Out Our Latest Research Report on AMETEK
Insider Activity
In other news, Director Steven W. Kohlhagen sold 1,320 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $189.41, for a total transaction of $250,021.20. Following the transaction, the director now directly owns 22,029 shares of the company’s stock, valued at $4,172,512.89. This represents a 5.65 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.61% of the company’s stock.
AMETEK Profile
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Featured Stories
- Five stocks we like better than AMETEK
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- How to Protect Your Portfolio When Inflation Is Rising
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What Investors Need to Know About Upcoming IPOs
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.